Earnings · China A-shares
Zhejiang East Asia Pharmaceutical Co., Ltd. Class A (605177) earnings
Zhejiang East Asia Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-30: net profit -172.66% year on year, -152.56% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -3.46% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -172.66%
- Excl. one-offs YoY
- -152.56%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -3.79% | — |
| 3 days | -3.46% | — |
| 7 days | -6.26% | — |
| 14 days | -22.84% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 4 of 7 reports (average +1.95%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | -¥197.43M | -172.66% | — | +2.12% | -1.72 | -11.50% | -3.46% | — | — |
| 2026 interim report | 2026-08-31 | -¥118.38M | -291.61% | — | +12.09% | -1.03 | -6.75% | +9.28% | +3.40% | +12.74% |
| 2026 Q1 report | 2026-04-30 | -¥35.20M | -408.73% | — | +38.58% | -0.31 | -1.97% | -2.66% | -4.74% | -6.79% |
| 2025 annual report | 2026-04-23 | -¥82.39M | +18.15% | +3.96% | -21.54% | -0.72 | -4.48% | +3.80% | -0.49% | +1.07% |
| 2025 Q3 report | 2025-10-31 | -¥72.41M | -260.31% | — | -38.08% | -0.63 | -3.93% | +2.87% | -8.70% | -4.02% |
| 2025 interim report | 2025-08-29 | -¥30.23M | -193.09% | — | -35.85% | -0.26 | -1.62% | -0.40% | -3.84% | -5.11% |
| 2025 Q1 report | 2025-04-30 | -¥6.92M | -128.78% | — | -45.85% | -0.06 | -0.37% | +4.21% | +10.88% | +7.70% |
| 2024 annual report | 2025-04-30 | -¥100.66M | -183.02% | — | -11.66% | -0.90 | -5.19% | +4.21% | +10.88% | +7.70% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.